Neuralink does not have to divulge even basic details about its trial, including the facility where patients are being implanted with the device and monitored, as well as the number of participants and expected completion date. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
